158 related articles for article (PubMed ID: 25076153)
1. Optimal matching ratios in drug safety surveillance.
Wang SV; Schneeweiss S; Rassen JA
Epidemiology; 2014 Sep; 25(5):772-3. PubMed ID: 25076153
[No Abstract] [Full Text] [Related]
2. Unmeasured confounding in pharmacoepidemiology.
Groenwold RH; de Groot MC; Ramamoorthy D; Souverein PC; Klungel OH
Ann Epidemiol; 2016 Jan; 26(1):85-6. PubMed ID: 26559329
[No Abstract] [Full Text] [Related]
3. Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making.
Etminan M; Gill S; Fitzgerald M; Samii A
J Clin Pharmacol; 2006 Jan; 46(1):6-9. PubMed ID: 16397278
[TBL] [Abstract][Full Text] [Related]
4. Variable selection for propensity score estimation via balancing covariates.
Zhu Y; Schonbach M; Coffman DL; Williams JS
Epidemiology; 2015 Mar; 26(2):e14-5. PubMed ID: 25643109
[No Abstract] [Full Text] [Related]
5. Propensity score balance measures in pharmacoepidemiology: a simulation study.
Ali MS; Groenwold RH; Pestman WR; Belitser SV; Roes KC; Hoes AW; de Boer A; Klungel OH
Pharmacoepidemiol Drug Saf; 2014 Aug; 23(8):802-11. PubMed ID: 24478163
[TBL] [Abstract][Full Text] [Related]
6. Matching by propensity score in cohort studies with three treatment groups.
Rassen JA; Shelat AA; Franklin JM; Glynn RJ; Solomon DH; Schneeweiss S
Epidemiology; 2013 May; 24(3):401-9. PubMed ID: 23532053
[TBL] [Abstract][Full Text] [Related]
7. One-to-many propensity score matching in cohort studies.
Rassen JA; Shelat AA; Myers J; Glynn RJ; Rothman KJ; Schneeweiss S
Pharmacoepidemiol Drug Saf; 2012 May; 21 Suppl 2():69-80. PubMed ID: 22552982
[TBL] [Abstract][Full Text] [Related]
8. A tutorial on the use of instrumental variables in pharmacoepidemiology.
Ertefaie A; Small DS; Flory JH; Hennessy S
Pharmacoepidemiol Drug Saf; 2017 Apr; 26(4):357-367. PubMed ID: 28239929
[TBL] [Abstract][Full Text] [Related]
9. Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice.
Weldeselassie YG; Whitaker HJ; Farrington CP
Epidemiol Infect; 2011 Dec; 139(12):1805-17. PubMed ID: 21849099
[TBL] [Abstract][Full Text] [Related]
10. Did thirst-blockers contribute to the exorbitant number of fatalities during the French 2003 heat wave?
Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):312-3. PubMed ID: 18300324
[No Abstract] [Full Text] [Related]
11. Evaluating the Utility of Coarsened Exact Matching for Pharmacoepidemiology Using Real and Simulated Claims Data.
Ripollone JE; Huybrechts KF; Rothman KJ; Ferguson RE; Franklin JM
Am J Epidemiol; 2020 Jun; 189(6):613-622. PubMed ID: 31845719
[TBL] [Abstract][Full Text] [Related]
12. Use of propensity score technique to account for exposure-related covariates: an example and lesson.
Seeger JD; Kurth T; Walker AM
Med Care; 2007 Oct; 45(10 Supl 2):S143-8. PubMed ID: 17909373
[TBL] [Abstract][Full Text] [Related]
13. Use of self-controlled designs in pharmacoepidemiology.
Hallas J; Pottegård A
J Intern Med; 2014 Jun; 275(6):581-9. PubMed ID: 24635348
[TBL] [Abstract][Full Text] [Related]
14. A conditional maximized sequential probability ratio test for pharmacovigilance.
Li L; Kulldorff M
Stat Med; 2010 Jan; 29(2):284-95. PubMed ID: 19941282
[TBL] [Abstract][Full Text] [Related]
15. 'Why me?' versus 'why now?'--differences between operational hypotheses in case-control versus case-crossover studies.
Maclure M
Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):850-3. PubMed ID: 17636552
[No Abstract] [Full Text] [Related]
16. Approaches to combat with confounding by indication in observational studies of intended drug effects.
McMahon AD
Pharmacoepidemiol Drug Saf; 2003; 12(7):551-8. PubMed ID: 14558178
[TBL] [Abstract][Full Text] [Related]
17. Multivariable confounding adjustment in distributed data networks without sharing of patient-level data.
Toh S; Reichman ME; Houstoun M; Ding X; Fireman BH; Gravel E; Levenson M; Li L; Moyneur E; Shoaibi A; Zornberg G; Hennessy S
Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1171-7. PubMed ID: 23878013
[TBL] [Abstract][Full Text] [Related]
18. An application of propensity score matching using claims data.
Seeger JD; Williams PL; Walker AM
Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):465-76. PubMed ID: 15651087
[TBL] [Abstract][Full Text] [Related]
19. Supplementary data collection with case-cohort analysis to address potential confounding in a cohort study of thromboembolism in oral contraceptive initiators matched on claims-based propensity scores.
Eng PM; Seeger JD; Loughlin J; Clifford CR; Mentor S; Walker AM
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):297-305. PubMed ID: 18215000
[TBL] [Abstract][Full Text] [Related]
20. Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system.
Rassen JA; Schneeweiss S
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():41-9. PubMed ID: 22262592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
